Bradley Jack A. reports trust transfer and two insider sales at $3.50/$3.30
Rhea-AI Filing Summary
Bradley Jack A., a director of GSI Technology, reported multiple transactions in Form 4. The filing shows a prior transfer on November 2, 2021 of 5,000 shares to The Bradley-Richards Family Trust for no consideration; the reporting person and spouse are co-trustees and beneficiaries and remain beneficial owners of trust-held shares.
The current report discloses sales of 1,100 shares on 08/06/2025 at $3.50 per share and 6,900 shares on 08/07/2025 at $3.30 per share. Table entries indicate an 8,000 share indirect holding associated with the family trust at one point and show that following the 08/07/2025 sale the trust-held indirect ownership is 0. The form is signed by an attorney-in-fact, Douglas Schirle, dated 08/08/2025.
Positive
- Transparent disclosure of insider transactions and a prior transfer to a family trust on Form 4
- Detailed trade data provided with dates, share counts, and prices for the 08/06/2025 and 08/07/2025 sales
- Explanation clarifies that the 11/02/2021 transfer to The Bradley-Richards Family Trust was for no consideration and that the reporting person and spouse are co-trustees and beneficiaries
Negative
- Insider sales totaling 8,000 shares (1,100 at $3.50 and 6,900 at $3.30) were reported on 08/06/2025–08/07/2025, reducing trust-held indirect ownership to 0 per the table
- Form lacks context on total company shares or percentage ownership, so the filing alone does not indicate materiality to investors
Insights
TL;DR: Director disclosed routine insider sales totaling 8,000 shares across two days, and a prior transfer to a family trust.
The filings document two cash sales: 1,100 shares at $3.50 on 08/06/2025 and 6,900 shares at $3.30 on 08/07/2025, totaling 8,000 shares sold. The 2021 transfer of 5,000 shares to The Bradley-Richards Family Trust is explicitly described as a no-consideration transfer with continued beneficial ownership by the reporting person and spouse as co-trustees and beneficiaries. From a market-impact perspective, these are clear disclosures but the filing does not provide context on total outstanding shares or percentage ownership, so materiality to valuation cannot be assessed from this form alone.
TL;DR: The Form 4 provides transparent disclosure of an earlier trust transfer and recent insider sales; governance appears compliant.
The explanation clarifies the November 2, 2021 transfer of 5,000 shares to a family trust and states the reporting person and spouse remain beneficial owners as co-trustees and beneficiaries. The contemporaneous sales on 08/06/2025 and 08/07/2025 are properly reported with prices and share counts. The filing was executed by an attorney-in-fact on 08/08/2025, indicating procedural adherence. The form does not allege any rule-based exemptions or trading plans beyond the checkboxes on the form, so assessment is limited to the disclosed facts.